platinum-based chemotherapySSGJ-707tislelizumab
…2 trial of SSGJ-707 or tislelizumab (control arm) combined with platinum-based chemotherapy in advanced NSCLC. Patients with histologically confirmed treat…
13articles mentioning treatments
17treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: platinum-based chemotherapy ×
platinum-based chemotherapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning platinum-based chemotherapy
13 articles · page 1 of 2ChTplatinum-based chemotherapypembrolizumabDurvalumabdostarlimab
… H.R (95% CI) Dostarlimab+ChT Reference Reference Pembrolizumab+ChT 0,8 (0,381-1,678) 0,526 (0,172-1,608) Atezolizumab+ChT 0,778 (0…
platinum-based chemotherapyNSCLCdocetaxeldatopotamab deruxtecannon-small cell lung cancer
…Immune checkpoint inhibitors combined with platinum-based chemotherapy have become the first-line backbone for advanced, driver-negati…
platinum-based chemotherapyanti-programmed cell death-ligand 1 immunotherapyUrothelial carcinomaFudan University Shanghai Cancer CenterZhongshan HospitalThe Cancer Genome Atlas
…high TAMs infiltration correlated with poorer responses to both platinum-based chemotherapy and anti-programmed cell death-ligand 1 immunotherapy specifica…
platinum-based chemotherapyniraparibtertiary hospitalPARP-2PARP-1
…ve achieved a complete or partial response following first-line platinum-based chemotherapy.Aim and Objectives To evaluate the real-world effectiveness and…
platinum-based chemotherapyChTdurvalumabPembrolizumabdostarlimabatezolizumabOlaparib
…geting PD-1 or PD-L1 are being investigated in combination with platinum-based chemotherapy (ChT). The absence of direct comparative studies limits informe…
platinum-based chemotherapyImmune checkpoint inhibitorsNSCLCnon-small cell lung cancer
…Immune checkpoint inhibitors combined with platinum-based chemotherapy have become the first-line backbone for advanced, driver-negati…
platinum-based chemotherapysitravatinibtislelizumabdocetaxel
…anced/metastatic NSCLC, who had disease progression on or after platinum-based chemotherapy and anti-PD-(L)1 antibodies. No more than two lines of prior sy…
platinum-based chemotherapydocetaxellung cancerpembrolizumabtislelizumabsitravatinib
…amous NSCLC who progressed on or after anti-PD-(L)1 therapy and platinum-based chemotherapy.HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Contin…
platinum-based chemotherapyradiosurgeryGleason 8 prostate adenocarcinomatertiary cancer centretaxanesmetastatic adenocarcinomametastatic clear cell seminal vesicle adenocarcinomaPARP inhibitor
…(ADP-ribose) polymerase (PARP inhibitor)), followed by taxanes, platinum-based chemotherapy and radiosurgery for brain metastases, he ultimately succumbed …
platinum-based chemotherapyvinorelbinedocetaxelTHIOgemcitabinecemiplimabNSCLCTHIO-104
… of systemic treatment, including at least one line of ICIs and platinum-based chemotherapy. Participants will be randomized 1:1 to receive either THIO 180…
platinum-based chemotherapybevacizumabChinese Academy of Medical Sciences Cancer HospitalShanxi Cancer HospitalNon-small cell lung cancersNSCLCs
… 2018–2022 (median follow-up 26.5 months), all of whom received platinum-based chemotherapy (± bevacizumab) in first- or second-line settings; 86 patients …